|
More articles from Pharma Marketletter
Verona's RPL554 enters toxicology study.(Verona Pharma Plc.)(Brief art..., October 15, 2007
Nanobac takes option on Calgenex technology.(Nanobac Pharmaceuticals I..., October 15, 2007
Survey finds disparities in drug access across EU.(European Union)(Sur..., October 15, 2007
Accentia agrees with FDA on Revimmune trial.(Brief article), October 15, 2007
UCB's Neupro effective for motor impairment in PD.(Brief article), October 15, 2007
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
